MyChesCo on MSN
Century Therapeutics Debuts Immune-Evasive Cell Therapy Aiming to Transform Type 1 Diabetes
Century Therapeutics, Inc. (NASDAQ: IPSC) has unveiled its first program targeting Type 1 diabetes, introducing an engineered ...
An early-screening and awareness campaign calling for greater understanding and support for people with Type 1 diabetes was ...
TipRanks on MSN
Century Therapeutics Launches Type 1 Diabetes Program
Century Therapeutics ( ($IPSC) ) just unveiled an announcement. On November 13, 2025, Century Therapeutics announced the launch of its first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback